How many molecules of antibody are needed for neutralization ?
This problem was aired by Daniels (1975) who argued that when the rate of neutralization was retarded by lowering the temperature or by using low concentrations of antibody, the reaction was seen to be multi-hit. However, this did not alter the fact that neutralization still only required a few molecules of antibody which would block only some of the binding sites of the virus. These data were obtained with polyclonal antibodies and other interpretations are possible but the use of monoclonal antibodies has allowed Chanas et al. (1982a) and Peiris et al. (1982) to show categorically that when the togaviruses, Sindbis and West Nile, are neutralized more than one molecule of antibody is attached to each virus particle. Their experiments showed that after neutralizing activity had been diluted out, the presence of monoclonal antibody on the surface of particles could be demonstrated by their enhanced infectivity towards cells bearing Fc receptors. In other words, neutralization requires more molecules of antibody per particle than does enhancement.
Unfortunately, these systems have not been quantified and we have no estimate of the number of molecules of antibody required for neutralization. However, using neutralizing polyclonal or monoclonal antibody directed towards the HA of A/FPV/Rostock/34 influenza virus, 50~ neutralization was observed with about 50 molecules of antibody per particle (H. P. Taylor & N. J. Dimmock, unpublished data) . This was calculated by using 125I-radiolabelled antibody of known specific activity (c.p.m./~g IgG) and estimating the number of HA spikes per particle both by electron microscopy and biochemical analysis. As this strain proved to have approximately 1000 HA spikes per particle, there would appear to be a sufficient number of spikes left unattached to antibody to bind to cellular receptors. Nor does it seem likely that antibody could interfere sterically with all those free HA spikes since an IgG molecule (mol. wt. 155 000) is of comparable size to the HA spikes (mol. wt. 240000). Similar conclusions have been reached for a non-enveloped virus. Poliovirus has a capsid consisting of 60 identical subunits and requires about three molecules of a monoclonal antibody per particle to achieve 50~ neutralization (Icenogle et al., 1983) .
Essentially, monoclonal antibodies have confirmed the earlier work with polyclonal sera that neutralization is apparently achieved by too few molecules of antibody to interfere with attachment, but what of such experiments?
Binding of neutralized virus to host cells
Contrary to 'popular' belief there are data in the literature showing that some neutralized viruses bind efficiently to their host cells. For instance, rabbitpox virus (Joklik, 1964) and poliovirus (Mandel, 1967) neutralized by polyclonal antibodies bind to HeLa cells. The latter finding has been recently confirmed using monoclonal antibodies (Emini et al., 1983 a) , although antibody to one epitope did inhibit binding even under non-saturating conditions. Apart from this exception, increasing the amounts of the monoclonal antibodies to saturation did inhibit attachment, presumably by steric hindrance. Type A influenza viruses neutralized with polyclonal or monoclonal IgG to the HA bound to a variety of different cell types (human, hamster, mouse and chicken) at temperatures from 4 to 37 °C with kinetics which were indistinguishable from un-neutralized virus (Possee & Dimmock, 1981 ; Dimmock et al., 1984; H. P. Taylor & N. J. Dimmock, unpublished data) . Even when all available sites on the HA were saturated with antibody, the kinetics of attachment was unaffected (H. P. Taylor & N. J. Dimmock, unpublished data) . This observation is less surprising now that it has been demonstrated that the cellular binding site on the HA is distinct from the neutralization sites (Rogers et al., 1983) . However, neutralized influenza virus did not enter cells of the chorioallantoic membrane (Dourmashkin & Tyrrell, 1974) so it is important to specify the cell system used. Attachment of a virus can be prevented by neutralizing monoclonal antibody (reovirus to L cells: Lee et al., 1981) although here the quantitative relationship between neutralization and inhibition of attachment was not investigated. The class of antibody is also important because secretory IgA, but not monomeric IgA derived from it, prevented the attachment of influenza virus (H. P. Taylor & N. J. Dimmock, unpublished data). Thus, the mechanism of neutralization will depend on the cell, the virus and the class of the neutralizing antibody. One last complicating factor is the binding of neutralized virus to novel receptors not used by un-neutralized virus (vesicular stomatitis virus: Schlegel & Wade, 1983) .
What about interactions of neutralized influenza virus with red blood cells ? Haemagglutination is mediated through the crosslinking of red cells by virus and is inhibited by neutralizing antibody. The binding of neutralized virus to red cells is also inhibited, although the same neutralized virus binds normally to cultured cells (Possee, 1981 and see above) . The nature of this difference is unknown, but it could be explained if receptor molecules on cultured but not red cells were sufficiently long to penetrate beyond the fringe of antibody to the HA binding site. This is possible as neutralizing antibody does not bind directly to the latter (Rogers et al., 1983) . Whatever the reason may be, red cells are evidently a poor model for infectious processes.
How do neutralized viruses lose infectivity ?
The only information available relates to two enveloped viruses (influenza and Sindbis) and a single non-enveloped virus (polio). With regard to neutralizing antibody-binding sites on virus there is detailed information available only for influenza A viruses where these have been mapped with regard to the three-dimensional structure of the HA Caton et al., 1982) . The region encoding the binding site for the cellular receptor is also known (Rogers et al., 1983) .
Influenza viruses (type A)
Since, as discussed above, attachment was not inhibited by neutralizing antibody we presume that the inhibition of some subsequent stage of infection is responsible for the loss of infectivity. Fortunately, uncoating and penetration of relatively small amounts of influenza virus (102 to 103 particles/cell) can be measured by isolating nuclei in which virion RNA accumulates; the HA, NA and virus lipid remain cytoplasmic (Stephenson & Dimmock, 1975 ; Possee et al., 1982) . For these experiments it is essential to use virus with a low particle :p.f.u. ratio, because with less infectious virus the majority of virion RNA does not enter the nucleus. When neutralized virus inoculated onto CEF or BHK cells was examined in this way the kinetics of uncoating were indistinguishable from the un-neutralized control virus (Possee et al., 1982; Dimmock et al., 1984) . The similarity in kinetics argues that un-neutralized and neutralized influenza virus follow the same route from the plasma membrane to the nucleus.
Despite the apparent normality of infection leading to the accumulation of virion RNA in the nucleus, ceils inoculated with neutralized virus synthesized no detectable virus RNA or proteins. Not even primary transcription was detected (Possee et al., 1982) , and the authors suggested that the activity of the virion transcriptase had been impaired by neutralization. This view was supported by in vitro studies which showed that transcription was inhibited by monoclonal anti-HA neutralizing antibody. However, as the drop in transcriptase activity (three-to tenfold) is much less than the loss of infectivity (> 99.99 ~), the significance of the in vitro data is not clear. One possible explanation relates to the complicated transcriptional process by which influenza virus obtains cap structures from cellular mRNA (Krug, 1983) . The in vitro transcription reaction described above measured only the template-dependent step and no data are available on the earlier stages of cap recognition and subsequent endonucleolytic cleavage of cell mRNA by neutralized virus. However, inhibition of transcription was specific and required intact virus, since addition of antibody to virus after it had been mixed with detergent necessary for the transcriptase assay did not inhibit transcription (A. S. Carver & N. J. Dimmock, unpublished data) . Neither in the cell nor in vitro did neutralizing antibody potentiate degradation of virion RNA (Possee et al., 1982) .
Thus, we have the situation that neutralizing antibody directed to a surface glycoprotein does not inhibit the attachment, penetration, uncoating of virus or transport into the nucleus of the uncoated RNA. But it does inhibit the function of the transcriptase complex which, of course, is on the other side of the viral envelope. Presumably the antibody initiates a signal (possibly a conformational change in the structure of the HA) which is transmitted across the envelope via the transmembrane segment of HA2 to the transcriptase. This would be analogous to the way in which some extracellular effectors (e.g. non-steroid hormones, interferons) exert their effects on macromolecular synthesis by attaching to receptors in the plasma membrane. The effect on the transcriptase could be positive or negative but does not require the continued presence of anti-HA antibody as the HA remains cytoplasmic while the transcriptase complex enters the nucleus. While as yet, there is no evidence of communication between HA and the transcriptase complex (although M protein would be a likely intermediary), conformational changes in the HA have been shown to result from binding certain monoclonal antibodies (Lubeck & Gerhard, 1982) .
Sindbis virus
The envelope spikes of Sindbis virus are an equimolar complex of E 1 and E2 polypeptides. A similar structure in the cell is composed of E1 together with the precursor PE2. A monoclonal antibody to E1 co-precipitates PE2 together with E1 but another monoclonal antibody only precipitates E1 (Clegg et al., 1983) . The authors concluded that binding of the second type of antibody causes conformational changes which dissociate the polypeptide complex. There is independent evidence of conformational rearrangements, as the binding of monoclonal antibodies to other sites on the molecule can be enhanced. This synergism also occurs when the appropriate antibodies are reacted with virus particles and, although quantitative measurements were not made, evidence from electron microscopy could be interpreted as enhanced binding (Chanas et al., 1982 b) . Neutralization of infectivity is also increased synergistically (see also below). However, it is not known how the infectivity of the virus is impaired.
Poliovirus
Work with polyclonal antibodies suggested that the capsid of poliovirus and also a bovine picornavirus underwent conformational changes during neutralization. Poliovirus oscillates between two isoelectric forms with pls of about 7 and 4, of which only the former is infectious. When virus is neutralized, the pI is shifted and 'frozen' at 4 (Mandel, 1976) . The pI shift could not be explained by the charge associated with addition of IgG and was presumably due to alterations in charged groups exposed on the surface of the virus. A similar conclusion was reached by Carthew (1976) who found that when bovine enterovirus was iodinated before and after neutralization, a different pattern of radioactive virion polypeptides was obtained. Such conformational changes might well affect initial stages of infection such as the release of virus RNA (Svehag, 1968) .
Studies with monoclonal antibodies to poliovirus type 1 capsid protein VP 1 confirmed that a change in pI accompanies neutralization (Emini et al., 1983b) . Monoclonal antibodies did not prevent attachment (with one exception) or penetration but all prevented transcription. Interpretation of the attachment data is uncertain as virus neutralized with certain monoclonal antibodies attached even to mouse cells, which lack poliovirus receptors. The penetration data also should be interpreted with caution as in fact the majority of virus did not enter the cells. Nonetheless, some neutralizing monoclonal antibodies to VP1 of type 3 poliovirus prevented attachment to cells while others did not (P. D. Minor, personal communication). Emini et al. (1983a) generally agree with Mandel (1976) that neutralization causes conformational changes to the capsid which prevent uncoating and/or transcription. However, in another study, Icenogle et al. (1983) favour the view that their monoclonal antibody cross-links the pentameric subunits of the virus capsid and interferes in this way with subsequent essential functions. This antibody did not react with any denatured virion proteins and was presumably directed against a conformation-dependent determinant (Icenogle et al., 1981) . However, despite this disagreement both groups hint that there is more than one mechanism of neutralization, i.e. monoclones did/did not prevent attachment (Emini et al., 1983a) , did/did not cause a change in capsid conformation (Icenogle et al., 1983) . The recent report that there were neutralizing (polyclonal) antibodies specific for VP1, VP2 and VP3 (Dernick et al., 1983) gives further scope for such variations, especially as anti-VP3 neutralizes but does not shift the particle pI (Emini et al., 1983 b) . [Note that this 'anti-VP3' was originally called anti-VP4 but the authors consider that the significant antibodies bind within VP3 (Emini et al., 1983b) .] Yet another parameter of neutralization is an enhanced ability of some neutralizing monoclonal antibodies to aggregate particles of type 3 poliovirus into clumps; strangely, this does not affect uptake into host cells (P. D. Minor, personal communication).
Cooperative neutralization
So far we have discussed neutralization which results from the binding of monoclonal antibodies of just one specificity, but natural polyclonal sera contain antibodies to several different epitopes, the number depending on the phenomenon of immunodominance. Evidence is now emerging that there can be cooperative neutralization in which the combined interaction of two monoclonal antibodies results in a greater loss of infectivity than the sum of their effects individually. There are two forms of such cooperativity: first where binding of an antibody synergistically increases binding by antibody to a different epitope and second where there is enhanced neutralization without increased binding of antibody. Synergistic binding of monoclonal antibodies has been detected in competition binding assays with influenza virus (Lubeck & Gerhard, 1982) , vesicular stomatitis virus (VSV) (Lefrancois & Lyles, 1982) , La Crosse virus (Kingsford et al., 1983) , bovine leukaemia virus (Bruck et al., 1982) and Sindbis virus (Clegg et al., 1983) . Such synergism has been associated with increased neutralization with La Crosse virus (Kingsford & Ishizawa, 1984; L. Kingsford, personal communication) and Sindbis virus (Clegg et al., 1983) . The second category was defined by Kingsford (personal communication) from work on La Crosse virus and she suggests that, as there is no synergistic increase in bound antibody, enhanced neutralization results from conformational changes in virus proteins which result from binding particular pairs of monoclonal antibodies. Volk et al. (1982) also found synergistic neutralization with VSV but did not investigate if this correlated with increased binding.
Does neutralization depend on the bivalency of immunoglobulins ?
This question encompasses two separate problems. Firstly, does neutralization depend on the affinity of the antibody for its epitope? Secondly, does neutralization depend in some way on antibody cross-linking surface proteins of the virus? Both were approached by Lafferty (1963) who concluded that monovalent (Fab) fragments neutralized influenza virus with comparable efficiency to antibody but that neutralization was reversed on dilution. Clearly no cross-linking was necessary. Early work on poliovirus also showed that Fab neutralized (Vogt et al., 1964; Keller, 1966) . But later Keller (1968) digested antibody already bound to poliovirus with papain, an approach used back in 1943 by Kalmanson & Bronfenbrenner; this partially reactivated infectivity but not through dissociation of binding, since virus could be re-neutralized by antiimmunoglobulin. The latter also suggested that cross-linking was necessary for neutralization. The same approach was taken recently by Emini et al. (1983c) and Icenogle et al. (1983) who demonstrated that neutralization (by anti-VP1 : Emini et al., 1983c) was reversed by papain digestion. Again the presence on virus of antibody fragments was demonstrated by reaction with anti-immunoglobulin. Both groups conclude that cross-linking is an integral part of neutralization by these antibodies (but not others: see below) but disagree no further interpretation. (One point which needs clearing up is how many of the Fab molecules remain on the virus after papain treatment: dissociation of some Fab would complicate the interpretation that neutralization was solely due to crosslinking of particular determinants.) Interestingly, Emini et al. (1983c) show that the shift in pI which accompanies neutralization by anti-VP1 is reversed by papain digestion and is restored on addition of the anti-immunoglobulin. However, the situation with anti-VP3 is totally different. Neutralization by this antibody, which does not cause a change in pI of the virus, is not reversed by papain digestion. Thus, the mechanism of neutralization of poliovirus differs according to which capsid protein antibody attaches to.
GENERAL CONCLUSIONS
Despite the evident complexity of neutralization it is still apparent that some neutralizing antibodies can block attachment of some viruses to cellular receptors, but on current information this mechanism seems uncommon. There is an increasing body of information which demonstrates that antibodies can induce conformational changes in virus proteins and these may be concerned with the neutralization process. Such changes may exert their effects close to the antigenic site or even in an entirely different protein. Different viruses almost certainly have different mechanisms of neutralization and the mechanism may depend on the type of host cell (Table 1) . If confirmed, this aspect will be important when considering protection of differentiated cells involved in infection of the natural host. Extrapolation from work with monoclonal antibodies suggests that neutralization by polyclonal sera is likely to be the sum of a number of different types of neutralization mechanism, with the possibility of 
Some mechanisms of neutralization*
Normal functioning of synergistic action between antibodies to different determinants being of importance. However, if viruses had relatively few dominant antigenic determinants, polyclonal sera would not be too dissimilar in their effects from a particular monoclonal antibody. Thus, there seems no basis today for a general theory of neutralization except in the sense that it is a highly specific process, only occurring when antibody is bound to certain antigenic determinants. However, this review and its conclusions are in a sense premature as there are few data and these deal almost exclusively with neutralization by IgG. It remains to be seen if the larger molecules of IgM and secretory IgA are equally fastidious in their action or neutralize by sterically hindering attachment to cellular receptors. The conclusion that there are 'neutralizing' antigenic determinants allows non-neotralizing antibody to be defined as antibody that binds to any other determinant, even one situated on the same molecule. Hence, a possible explanation of the intriguing fact that infection or immunization with African swine fever virus (ASFV) elicits only non-neutralizing antibody (Hess, 1981) is that ASFV lacks the specific determinants through which neutralization is triggered. How ASFV evolved to this situation and why, with the possible exception of Aleutian disease virus (Porter & Cho, 1980) , Lassa fever and Mopeia viruses (M. P. Kiley, unpublished data), others have not evolved the loss of neutralizing antigenic sites is another question.
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